Bright Futures and Genomic Duties
By Jonathan Kahn, Biopolitical Times guest contributor
| 04. 20. 2011
A recent issue of Nature reviewed the accomplishments of the Human Genome Project 10 years after the grand announcement of the completion of the first draft of the human genome. With a cover declaring "The Future is Bright," the issue featured an article by Eric Green, the new director of National Human Genome Research Institute, and others [pdf] that was intended to "articulate a 2011 vision for the future of genomics research and describe the path towards an era of genomic medicine."
Understandably, the authors accentuate the positive and express both hope and enthusiasm for the future of genomic research. To realize the great promise of ongoing genomic research, they also identify several "imperatives for genomic medicine," specifically:
- Making genomics-based diagnostics routine
- Defining the genetic components of disease
- Comprehensive characterization of cancer genomes
- Practical systems for clinical genomic informatics
- The role of the human microbiome in health and disease
These are relatively unexceptional goals and certainly worthy of pursuit. To propel genomic research down this path, however, the authors also declare that "Effective genomics research needs continual, broad...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...